345 related articles for article (PubMed ID: 28863773)
1. Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding.
Baltruskeviciene E; Schveigert D; Stankevicius V; Mickys U; Zvirblis T; Bublevic J; Suziedelis K; Aleknavicius E
BMC Cancer; 2017 Sep; 17(1):607. PubMed ID: 28863773
[TBL] [Abstract][Full Text] [Related]
2. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer.
Qiu X; Zhu H; Liu S; Tao G; Jin J; Chu H; Wang M; Tong N; Gong W; Zhao Q; Qiang F; Zhang Z
J Gastroenterol Hepatol; 2017 Apr; 32(4):819-827. PubMed ID: 27529338
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727
[TBL] [Abstract][Full Text] [Related]
5. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
[TBL] [Abstract][Full Text] [Related]
6. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
7. miRNA-148a-3p Regulates Immunosuppression in DNA Mismatch Repair-Deficient Colorectal Cancer by Targeting PD-L1.
Ashizawa M; Okayama H; Ishigame T; Thar Min AK; Saito K; Ujiie D; Murakami Y; Kikuchi T; Nakayama Y; Noda M; Tada T; Endo H; Fujita S; Sakamoto W; Saito M; Saze Z; Momma T; Ohki S; Mimura K; Kono K
Mol Cancer Res; 2019 Jun; 17(6):1403-1413. PubMed ID: 30872332
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer.
Takahashi M; Cuatrecasas M; Balaguer F; Hur K; Toiyama Y; Castells A; Boland CR; Goel A
PLoS One; 2012; 7(10):e46684. PubMed ID: 23056401
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Deregulated microRNAs and Their Target Genes in Gastric Cancer.
Juzėnas S; Saltenienė V; Kupcinskas J; Link A; Kiudelis G; Jonaitis L; Jarmalaite S; Kupcinskas L; Malfertheiner P; Skieceviciene J
PLoS One; 2015; 10(7):e0132327. PubMed ID: 26172537
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of microRNA-148a in patients with early relapse of stage II stage and III colorectal cancer after curative resection.
Tsai HL; Yang IP; Huang CW; Ma CJ; Kuo CH; Lu CY; Juo SH; Wang JY
Transl Res; 2013 Oct; 162(4):258-68. PubMed ID: 23933284
[TBL] [Abstract][Full Text] [Related]
11. Different miR-21-3p isoforms and their different features in colorectal cancer.
Jiao W; Leng X; Zhou Q; Wu Y; Sun L; Tan Y; Ni H; Dong X; Shen T; Liu Y; Li J
Int J Cancer; 2017 Nov; 141(10):2103-2111. PubMed ID: 28734015
[TBL] [Abstract][Full Text] [Related]
12. The association of miR-126-3p, miR-126-5p and miR-664-3p expression profiles with outcomes of patients with metastatic colorectal cancer treated with bevacizumab.
Fiala O; Pitule P; Hosek P; Liska V; Sorejs O; Bruha J; Vycital O; Buchler T; Poprach A; Topolcan O; Finek J
Tumour Biol; 2017 Jul; 39(7):1010428317709283. PubMed ID: 28714375
[TBL] [Abstract][Full Text] [Related]
13. Significance of miR-148a in Colorectal Neoplasia: Downregulation of miR-148a Contributes to the Carcinogenesis and Cell Invasion of Colorectal Cancer.
Hibino Y; Sakamoto N; Naito Y; Goto K; Oo HZ; Sentani K; Hinoi T; Ohdan H; Oue N; Yasui W
Pathobiology; 2015; 82(5):233-41. PubMed ID: 26389729
[TBL] [Abstract][Full Text] [Related]
14. Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapy.
Manceau G; Imbeaud S; Thiébaut R; Liébaert F; Fontaine K; Rousseau F; Génin B; Le Corre D; Didelot A; Vincent M; Bachet JB; Chibaudel B; Bouché O; Landi B; Bibeau F; Leroy K; Penault-Llorca F; Van Laethem JL; Demetter P; Tejpar S; Rossi S; Mosakhani N; Osterlund P; Ristamäki R; Sarhadi V; Knuutila S; Boige V; André T; Laurent-Puig P
Clin Cancer Res; 2014 Jun; 20(12):3338-47. PubMed ID: 24771647
[TBL] [Abstract][Full Text] [Related]
15. Signature miRNAs in colorectal cancers were revealed using a bias reduction small RNA deep sequencing protocol.
Sun G; Cheng YW; Lai L; Huang TC; Wang J; Wu X; Wang Y; Huang Y; Wang J; Zhang K; Hu S; Yang JR; Yen Y
Oncotarget; 2016 Jan; 7(4):3857-72. PubMed ID: 26646696
[TBL] [Abstract][Full Text] [Related]
16. microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer.
Takahashi H; Takahashi M; Ohnuma S; Unno M; Yoshino Y; Ouchi K; Takahashi S; Yamada Y; Shimodaira H; Ishioka C
BMC Cancer; 2017 Nov; 17(1):723. PubMed ID: 29115941
[TBL] [Abstract][Full Text] [Related]
17. Early metastatic colorectal cancers show increased tissue expression of miR-17/92 cluster members in the invasive tumor front.
Jepsen RK; Novotny GW; Klarskov LL; Bang-Berthelsen CH; Haakansson IT; Hansen A; Christensen IJ; Riis LB; Høgdall E
Hum Pathol; 2018 Oct; 80():231-238. PubMed ID: 29902577
[TBL] [Abstract][Full Text] [Related]
18. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y
Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793
[TBL] [Abstract][Full Text] [Related]
19. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
[TBL] [Abstract][Full Text] [Related]
20. microRNA-148a-3p inhibited the proliferation and epithelial-mesenchymal transition progression of non-small-cell lung cancer via modulating Ras/MAPK/Erk signaling.
Xie Q; Yu Z; Lu Y; Fan J; Ni Y; Ma L
J Cell Physiol; 2019 Aug; 234(8):12786-12799. PubMed ID: 30536836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
